BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity.

导出 OA

翻译打印收藏纠错

作者： Eui-Jun,Kim ^[1] ; Peng,Liu ^[2] ; Shengjie,Zhang ^[3] ; Kristine,Donahue ^[2] ; Yidan,Wang ^[1] ; Jennifer L,Schehr ^[1] ; Serena K,Wolfe ^[2] ; Amber,Dickerson ^[1] ; Li,Lu ^[2] ; Lixin,Rui ^[4] ; Xuehua,Zhong ^[2] ; Kari B,Wisinski ^[4] ; Min,Yu ^[2] ; Aussie,Suzuki ^[5] ; Joshua M,Lang ^[6] ; Irene M,Ong ^[7] ; Wei,Xu ^[8]

作者单位： McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53706, USA. ^[1] Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI 53706, USA. ^[2] Department of Biostatistics and Medical Informatics. School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706, USA. ^[3] Department of Medicine, University of Wisconsin, Madison, WI 53706, USA. ^[4] Department of Stem Cell Biology and Regenerative Medicine, and USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. ^[5] Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, WI 53715, USA. ^[6] Laboratory of Genetics, University of Wisconsin-Madison, Madison WI, USA. ^[7] Department of Obstetrics and Gynecology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53706, USA. ^[8]